Ionis Pharmaceuticals
IONS
IONS
329 hedge funds and large institutions have $6.36B invested in Ionis Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 90 increasing their positions, 116 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
329
Holders Change
+7
Holders Change %
+2.17%
% of All Funds
7.34%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.2%
New
51
Increased
90
Reduced
116
Closed
44
Calls
$64.2M
Puts
$112M
Net Calls
-$48M
Net Calls Change
-$27.4M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.9M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$35.3M |
| 3 |
Morgan Stanley
New York
|
+$25.8M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$22.4M |
| 5 |
Two Sigma Advisers
New York
|
+$16.1M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$90.2M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$27.6M |
| 3 |
State Street
Boston,
Massachusetts
|
-$25.9M |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$25.4M |
| 5 |
Goldman Sachs
New York
|
-$22.1M |
